LeMaitre Vascular

Health Technology hardware healthtech medical devices

LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. LeMaitre Vascular's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart.

Revenue(FY, 2017)

$100.9 M

Market capitalization(2018-04-25)

$781.5 M

Type

Public

Burlington, US

Founded

1983

Size (employees)

397 (est)

Website

lemaitre.com

LeMaitre Vascular was founded in 1983 and is headquartered in Burlington, US

Report incorrect company information

LeMaitre Vascular Office Locations

LeMaitre Vascular has offices in Burlington, Inzell, Chiyoda, Mississauga and in 4 other locations

Burlington, US (HQ)

63 Second Ave

North Melbourne, AU

36 Munster Terrace

Mississauga, CA

608 5915 Airport Rd

Inzell, DE

Otto-Volger-Str. 5 a/b 65843 Sulzbach/Ts

San Giuliano Milanese, IT

86 Viale Leone Tolstoj

Madrid, ES

Plaza de España

Show all (8)

Report incorrect company information

LeMaitre Vascular Financials and Metrics

LeMaitre Vascular Financials

LeMaitre Vascular's revenue was reported to be $100.87 m in FY, 2017

Summary

USD
Revenue (FY, 2017)	100.9 m
Gross profit (FY, 2017)	70.7 m
Gross profit margin (FY, 2017), %	70.1%
Net income (FY, 2017)	17.2 m
EBIT (FY, 2017)	21.1 m
Market capitalization (25-Apr-2018)	781.5 m
Cash (31-Dec-2017)	19.1 m

LeMaitre Vascular's current market capitalization is $781.5 m.

Income Statement

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Revenue	64.5 m	71.1 m	78.4 m	89.2 m	100.9 m
Revenue growth, %		10%	10%	14%
Cost of goods sold	19.4 m	22.7 m	24.2 m	26.2 m	30.2 m
Gross profit	45.1 m	48.4 m	54.2 m	62.9 m	70.7 m

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017
Revenue	15.3 m	16.8 m	18.2 m	17.5 m	18.9 m	19.9 m	19 m	20.3 m	22.4 m	23.2 m	24.1 m	25.8 m
Cost of goods sold	4.6 m	5.5 m	5.8 m	5.5 m	5.8 m	6.8 m	5.5 m	5.9 m	7 m	6.2 m	6.8 m	8.2 m
Gross profit	10.7 m	11.2 m	12.4 m	12 m	13.1 m	13.1 m	13.5 m	14.4 m	15.4 m	17 m	17.4 m	17.5 m
Gross profit Margin, %	70%	67%	68%	69%	69%	66%	71%	71%	69%	73%	72%	68%

show all

Balance Sheet

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Cash	14.7 m	18.7 m	27.5 m	24.3 m	19.1 m
Accounts Receivable				243.9 m
Inventories	3.2 m	2.4 m	3.6 m	2 m
Current Assets	41.7 m	48.6 m	58.2 m	59 m	80.3 m

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017
Cash	13.6 m	12.5 m	23.5 m	18.4 m	17 m	19.4 m	23.6 m	25.9 m	29.3 m	34.7 m	25.8 m	30.1 m
Inventories	13.1 m	14.2 m	15 m	16.9 m	16.5 m	15.8 m	15.9 m	17.9 m	17 m	17.4 m		20.5 m
Current Assets	39 m	40.3 m	53 m	49.4 m	47.8 m	50.3 m	54 m	59.7 m	62.4 m	68.2 m	62.5 m	68.1 m
PP&E	6 m	5.8 m	5.5 m	7.2 m	6.6 m	6.6 m	6.8 m	7.4 m	7.3 m	7.5 m	9.3 m	9.5 m

show all

Cash Flow

Annual

USD	FY, 2013	FY, 2014	FY, 2015	FY, 2016	FY, 2017
Net Income	3.2 m	3.9 m	7.8 m	10.6 m	17.2 m
Depreciation and Amortization	2.8 m	3.3 m	3.4 m	3.6 m	4.1 m
Inventories	(2.2 m)	(2.7 m)	608 k
Accounts Payable	861 k	(1.1 m)	2.6 m	(103 k)	1.5 m

Quarterly

USD	Q3, 2013	Q1, 2014	Q2, 2014	Q3, 2014	Q1, 2015	Q2, 2015	Q3, 2015	Q1, 2016	Q2, 2016	Q3, 2016	Q1, 2017	Q2, 2017
Net Income	2.5 m	(207 k)	1.1 m	2 m	1.4 m	3.1 m	5.2 m	2.2 m	4.8 m	8 m	3.2 m	7.9 m
Depreciation and Amortization	2 m	831 k	1.6 m	2.4 m	832 k	1.7 m	2.5 m	881 k	1.8 m	2.7 m	979 k	2 m
Inventories	(1.9 m)	(997 k)	(2.1 m)	(2.5 m)	(395 k)	351 k	(33 k)	(392 k)	264 k	(216 k)	(1.1 m)	(767 k)
Accounts Payable	273 k	(1.8 m)	(1.2 m)	(304 k)	(1.1 m)	(418 k)	214 k	(1.8 m)	(882 k)	1.2 m	(367 k)	(550 k)